{"id":621827,"title":"Consultation - Draft Guidance Document for Industry and Practitioners on the Special Access Program (SAP) for Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-26","captureTimestamp":"2026-02-26T00:32:59.485000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-industry-practitioners-special-access-program.html","snippet":"Consultation - Draft Guidance Document for Industry and Practitioners on the Special Access Program (SAP) for Drugs From Health Canada Current status: Closed This consultation ran from May 10, 2019 to July 19, 2019. This draft guidance provides information on the interpretation…","rawSnapshotUrl":"/api/snapshots/raw/621827","browseUrl":"https://replay.healtharchive.ca/job-6/20260226003259/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-industry-practitioners-special-access-program.html#ha_snapshot=621827","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}